Quanex Building Products CORP
Business
Quanex Building Products CORP manufactures and distributes components for original equipment manufacturers in the building products industry, serving fenestration, door, solar, refrigeration, cabinetry and access markets. It offers energy-efficient insulating glass spacers, extruded vinyl profiles, window and door screens, precision-formed metal and wood products, seals, hardware, sealants, trim moldings and other component products. The company operates distinct businesses for insulating glass, vinyl extrusion, fabricated metal and wood products, weather seals and commercial access solutions. It primarily serves customers in North America and the U.K., with facilities in Europe and Mexico and sales via a direct sales force, distributors and independent agents.
Summary from filing dated 2025-12-12
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-10-31 | FY 2024 2024-10-31 | FY 2023 2023-10-31 | FY 2022 2022-10-31 | FY 2021 2021-10-31 |
|---|---|---|---|---|---|---|
| Net sales | 1,838 | 1,278 | 1,131 | 1,222 | 1,072 | |
| Cost of sales (excluding depreciation and amortization) | 1,338 | 972 | 853 | 953 | 832 | |
| Selling, general and administrative | 277 | 190 | 124 | 117 | 116 | |
| Restructuring charges | 10 | 0 | 0 | 0 | 39,000 | |
| Depreciation and amortization | 103 | 60 | 43 | 40 | 43 | |
| Goodwill impairment charges | 302 | 0 | 0 | — | — | |
| Operating (loss) income | −194 | 55 | 111 | 111 | 82 | |
| Interest expense | −56 | −21 | −8 | −3 | −3 | |
| Other, net | 7 | 8 | −6 | 1 | 754,000 | |
| (Loss) income before income taxes | −243 | 42 | 97 | — | — | |
| Income tax expense | −8 | −9 | −15 | −21 | −23 | |
| Net (loss) income | −251 | 33 | 83 | 88 | 57 | |
| Basic (loss) earnings per common share | −5.43 | 0.91 | 2.51 | 2.67 | 1.72 | |
| Diluted (loss) earnings per common share | −5.43 | 0.9 | 2.5 | 2.66 | 1.7 | |
| Basic (in shares) | 46 | 36 | 33 | 33 | 33 | |
| Diluted (in shares) | 46 | 37 | 33 | 33 | 33 | |
| Cash dividends paid per common share (usd per share) | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-10-31 | FY 2024 2024-10-31 | FY 2023 2023-10-31 | FY 2022 2022-10-31 | FY 2021 2021-10-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 76 | 98 | 58 | 55 | 40 | |
| Restricted cash | 2 | 5 | 0 | — | — | |
| Accounts receivable, net of allowance for credit losses of $2,039 and $254 | 205 | 198 | 97 | 96 | 108 | |
| Inventories, net | 254 | 276 | 98 | 121 | 93 | |
| Income tax receivable | 0 | 6 | 8 | 0 | — | |
| Prepaid Expense, Current | 32 | 23 | — | — | — | |
| Other current assets | 4 | 6 | — | — | — | |
| Total current assets | 574 | 611 | 274 | 281 | 249 | |
| Property, plant and equipment, net of accumulated depreciation of $414,809 and $391,851 | 412 | 402 | 251 | 180 | 179 | |
| Operating lease right-of-use assets | 155 | 127 | 47 | 56 | 53 | |
| Deferred income tax assets | 3 | 4 | 0 | — | — | |
| Goodwill | 271 | 575 | 183 | 138 | 149 | |
| Intangible assets, net | 549 | 598 | 74 | 65 | 82 | |
| Other assets | 5 | 3 | 3 | 5 | 5 | |
| Total assets | 1,968 | 2,320 | 831 | 725 | 717 | |
| Accounts payable | 131 | 124 | 74 | 78 | 87 | |
| Accrued liabilities | 95 | 104 | 50 | 52 | 56 | |
| Income taxes payable | 12 | 7 | 384,000 | 1 | 6 | |
| Current maturities of long-term debt | 28 | 26 | 2 | 1 | 846,000 | |
| Current operating lease liabilities | 15 | 12 | 7 | 8 | 8 | |
| Total current liabilities | 282 | 273 | 135 | 140 | 158 | |
| Long-term debt | 665 | 737 | 66 | 30 | 52 | |
| Non-current operating lease liabilities | 145 | 118 | 40 | 49 | 45 | |
| Deferred income taxes | 136 | 162 | 29 | 22 | 22 | |
| Other liabilities | 14 | 19 | 15 | 13 | 14 | |
| Total liabilities | 1,242 | 1,309 | 286 | 260 | 298 | |
| Preferred stock, no par value, shares authorized 1,000,000 issued and outstanding - none | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.01 par value, shares authorized 125,000,000 issued 51,211,469 and 51,266,501 respectively; outstanding 45,674,726 and 47,252,070, respectively | 512,000 | 513,000 | 372,000 | 372,000 | 373,000 | |
| Additional paid-in-capital | 700 | 701 | 252 | 252 | 254 | |
| Retained earnings | 165 | 430 | 409 | 337 | 260 | |
| Accumulated other comprehensive loss | −35 | −46 | −38 | −49 | −22 | |
| Less: Treasury stock at cost, 5,536,743 and 4,014,431 shares, respectively | −104 | −75 | −78 | −76 | −73 | |
| Total stockholders equity | 726 | 1,011 | 546 | 465 | 420 | |
| Total liabilities and stockholders' equity | 1,968 | 2,320 | 831 | 725 | 717 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-10-31 | FY 2024 2024-10-31 | FY 2023 2023-10-31 | FY 2022 2022-10-31 | FY 2021 2021-10-31 |
|---|---|---|---|---|---|---|
| Net income | −251 | 33 | 83 | 88 | 57 | |
| Depreciation and amortization | 103 | 60 | 43 | 40 | 43 | |
| Loss (gain) on disposition of capital assets | 613,000 | −5 | 278,000 | 109,000 | 3 | |
| Stock-based compensation | 4 | 3 | 3 | 2 | 2 | |
| Deferred income tax | −19 | −15 | 5 | 2 | 2 | |
| Charge for deferred loan costs and debt discount | 0 | 3 | 0 | 0 | — | |
| Gain on deal contingent foreign exchange forward currency contract | 0 | 7 | 0 | 0 | — | |
| Noncash restructuring charges | 5 | 0 | 0 | — | — | |
| Other, net | 7 | 4 | 2 | 2 | 2 | |
| (Increase) decrease in accounts receivable | −7 | 973,000 | 7 | 7 | −19 | |
| Decrease in inventory | 24 | 33 | 30 | −32 | −31 | |
| (Increase) decrease in other current assets | −4 | 4 | −2 | −970,000 | −2 | |
| Increase (decrease) in accounts payable | 3 | −36 | −12 | −3 | 7 | |
| (Decrease) increase in accrued liabilities | −10 | 6 | −4 | −3 | 16 | |
| Increase (decrease) in current income taxes payable | 11 | 9 | −9 | −5 | −378,000 | |
| (Decrease) increase in other long-term liabilities | −5 | −7 | 683,000 | 305,000 | 477,000 | |
| Other, net | −556,000 | 411,000 | 1 | 194,000 | −528,000 | |
| Cash provided by operating activities | 165 | 89 | 147 | 98 | 79 | |
| Acquisitions, net of cash acquired | 0 | −399 | −91 | 0 | — | |
| Capital expenditures | −63 | −37 | −37 | −33 | −24 | |
| Proceeds from disposition of capital assets | 634,000 | 15 | 253,000 | 159,000 | 5 | |
| Cash used for investing activities | −62 | −421 | −128 | −33 | −19 | |
| Borrowings under credit facility | 190 | 785 | 102 | 71 | 0 | |
| Repayments of credit facility borrowings | −265 | −84 | −100 | −96 | −65 | |
| Debt issuance costs | 0 | −14 | 0 | −1 | 0 | |
| Repayments of other long-term debt | −4 | −296 | −3 | −2 | −680,000 | |
| Common stock dividends paid | −15 | −12 | −11 | −11 | −11 | |
| Issuance of common stock | 214,000 | 573,000 | 1 | 689,000 | 16 | |
| Proceeds from deal contingent foreign exchange forward currency contract | 0 | 7 | 0 | 0 | — | |
| Payroll tax paid to settle shares forfeited upon vesting of stock | −1 | −1 | −567,000 | −1 | −492,000 | |
| Purchase of treasury stock | −32 | 0 | −6 | −7 | −11 | |
| Cash (used for) provided by financing activities | −127 | 385 | −16 | −46 | −72 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | −286,000 | −9 | 919,000 | −4 | 421,000 | |
| (Decrease) increase in cash, cash equivalents and restricted cash | −25 | 45 | 3 | 15 | −12 |